Overall, these findings suggest an involvement of inflammation in the pathogenesis of glucotoxicity and highlight the role of the IL-1β/NF-kB pathway as a promising target to preserve or restore beta cell mass and function in patients with T2D. The gene discussed is NFKB1; the disease is type 2 diabetes mellitus.